Orris

APTT is used for Screening for hemophilia A and B and other possible coagulopathies (except factors VII and XIII. PTT is no affected by single clotting factor defects above 40% of normal. It is also used for detection of clotting inhibitors. This is best performed by mixing studies once an otherwise unexplained prolonged PTT is found. Results should be clinically correlated.

Reading File
Finding Sources
Finding Sources
Searching PubMed

"partial thromboplastin time" AND "mixing study"

Searching the Web

prolonged aPTT mixing study factor deficiency inhibitor clinical guidance

Revised version
Activated partial thromboplastin time (aPTT, often called PTT) is a screening test for abnormalities of the intrinsic and common coagulation pathways. It may be prolonged in hemophilia A (factor VIII deficiency), hemophilia B (factor IX deficiency), factor XI or XII deficiency, and deficiencies or inhibitors involving common-pathway factors. It is not a useful screen for isolated factor VII deficiency, which primarily prolongs PT, or factor XIII deficiency, which usually has normal PT and aPTT.
The aPTT may remain normal in mild single-factor deficiencies because assay sensitivity varies by reagent; clinically meaningful prolongation generally occurs only when the relevant factor level is reduced to roughly below 30% to 40% of normal. Therefore, a normal aPTT does not exclude mild hemophilia or some forms of von Willebrand disease.
An unexplained prolonged aPTT should be evaluated with a 1:1 mixing study using patient plasma and normal pooled plasma, ideally measured immediately and after incubation:
  • Correction of aPTT suggests a coagulation-factor deficiency.
  • Failure to correct suggests an inhibitor, such as lupus anticoagulant, a specific factor inhibitor, heparin contamination, or interference from an anticoagulant drug.
  • Initial correction followed by prolongation after incubation raises concern for a time-dependent inhibitor, particularly an acquired factor VIII inhibitor.
Results must be interpreted with the clinical history, bleeding or thrombotic phenotype, medication exposure, specimen quality, PT result, and targeted factor or lupus anticoagulant testing. A Cleveland Clinic laboratory guide describes the immediate and incubated mixing-study approach; a clinical diagnostic review also emphasizes interpreting aPTT patterns in relation to bleeding risk.

Conclusion

Conclusion:
aPTT is a useful screening test for intrinsic and common pathway coagulation defects, including hemophilia A and B. It does not detect isolated factor VII or factor XIII deficiency and may be normal in mild factor deficiencies. An unexplained prolonged aPTT should be followed by a 1:1 mixing study to distinguish factor deficiency from an inhibitor. Final interpretation always requires correlation with the patient’s bleeding history, medications, PT result, and confirmatory coagulation studies.

What does that means

Reading File
Searching the Web

aPTT mixing study factor deficiency inhibitor explanation

It means:
  • aPTT/PTT is a blood test that checks how long the blood takes to clot through part of the clotting system.
  • It helps detect problems such as hemophilia A (low factor VIII) and hemophilia B (low factor IX).
If the aPTT is prolonged, the person may have either:
  1. Too little of a clotting factor
    Example: hemophilia. The blood lacks enough of a protein needed to form a clot.
  2. An inhibitor
    This is something in the blood that interferes with clotting tests, such as lupus anticoagulant, heparin, or an antibody against a clotting factor.
A mixing study helps distinguish these two possibilities. The laboratory mixes the patient’s plasma with normal plasma:
  • If the aPTT becomes normal, it suggests a clotting-factor deficiency, because normal plasma supplied the missing factor.
  • If it stays prolonged, it suggests an inhibitor is interfering with clotting.
Factor VII and factor XIII are exceptions:
  • Factor VII deficiency is usually detected by the PT/INR test, not aPTT.
  • Factor XIII deficiency usually has normal PT and aPTT, so special testing is needed.
Finally, the result alone does not diagnose a condition. Doctors interpret it together with bleeding symptoms, medications such as heparin, family history, and more specific factor tests. This correction-versus-no-correction principle is also described by ARUP’s hemophilia testing guidance.
analyse_media
Reading File
Finding Sources
Searching PubMed

"partial thromboplastin time" AND "prothrombin time"

Searching the Web

mildly prolonged PT INR and aPTT causes evaluation laboratory guidance

The report shows mild prolongation of both clotting tests:
TestYour resultLab rangeMeaning
PT17.2 seconds11.6-16.6Slightly high
INR1.270.9-1.1Slightly high
aPTT40 seconds28.3-36.0Slightly high
In plain language: your blood took a little longer than this laboratory’s usual range to form a clot in both tests. These are small abnormalities, and by themselves they do not diagnose hemophilia or another specific bleeding disorder.
Because both PT/INR and aPTT are prolonged, an isolated hemophilia A or B pattern is less typical. Possible explanations include medication effects, especially blood thinners, liver-related changes, low vitamin K intake or absorption, an acute illness, alcohol-related liver injury, or sometimes a blood-sample/laboratory issue. Further testing is guided by symptoms, medical history, and repeat results. ARUP guidance recommends evaluating unexplained prolonged PT and aPTT with clinical context and, when appropriate, tests such as CBC/platelets, liver tests, fibrinogen, medication review, and targeted coagulation studies.
What to do
  • Show this report to the doctor who ordered it and ask whether it should be repeated, especially if you are not on anticoagulants.
  • Tell them about all medicines and supplements, including warfarin, heparin injections, apixaban/rivaroxaban/dabigatran, aspirin, antibiotics, and herbal products.
  • Mention any liver disease, jaundice, poor food intake, chronic diarrhea, heavy alcohol use, or recent infection.
  • If the abnormality persists, the clinician may consider a mixing study and factor/inhibitor testing.
Seek urgent medical care for uncontrolled bleeding, black stools, vomiting blood, severe headache after injury, blood in urine, or new extensive bruising.

Tell me

Reading File
Your report means your blood-clotting time is slightly slower than the laboratory’s normal range:
  • PT/INR slightly high
  • aPTT slightly high
This is a mild abnormality, not proof of hemophilia and not an emergency if there is no active bleeding.
Because both tests are mildly prolonged, the next step is usually to review medicines and repeat the tests. Common reasons include blood-thinning medicines, liver or vitamin K problems, recent illness, alcohol use, or occasionally a sample-related variation.
Please tell me:
  1. Is there any bleeding, easy bruising, black stool, or

Quick answer

Your PT/INR and aPTT are only mildly raised, meaning the blood took slightly longer than expected to clot in this test. This does not automatically mean hemophilia or a serious bleeding disorder.
The appropriate next step is to discuss it with the doctor who ordered the test. They may repeat PT/INR and aPTT and check CBC, liver function, and medication history. If you have no unusual bruising or bleeding, it is usually not an emergency.
Get urgent care if you have ongoing bleeding, black stools, vomiting blood, blood in urine, severe unexplained bruising, or a severe headache after an injury.

Dialysis px left av fistula

Reading File

Quick answer

If the person is on hemodialysis through a left AV fistula, this can help explain the mildly prolonged aPTT (40 seconds), especially if the blood sample was taken during or soon after dialysis.
During hemodialysis, heparin is commonly used to prevent clotting in the dialysis circuit. Heparin can prolong aPTT. Kidney failure and associated illness can also affect clotting results.
Important points:
  • A left AV fistula means dialysis access is in the left arm.
  • Do not take blood pressure, draw blood, or insert IV lines in that fistula arm unless the dialysis team specifically permits it.
  • The test should ideally be repeated before dialysis or well after heparin has cleared, as advised by the nephrologist.
  • The mild PT/INR and aPTT rise still needs clinical review, particularly if there is bleeding, bruising, black stools, blood in urine, or planned surgery/fistula intervention.
So, in this context, the result is more likely related to dialysis/heparin or chronic kidney disease than hemophilia, but the treating nephrologist should confirm it.

Dialysis px left av fistula

Dialysis patient with a left AV fistula means the person has chronic kidney failure and receives hemodialysis through a surgically created artery-to-vein connection in the left arm.
This matters because:
  • Heparin used during dialysis can mildly prolong the aPTT.
  • Blood for PT/aPTT should preferably be drawn from a peripheral vein, not from the fistula or a heparin-contaminated line.
  • Avoid blood pressure cuffs, injections, IV cannulas, and routine blood draws in the left fistula arm.
  • Check the fistula daily for a vibration or buzzing sensation, called a thrill. Absence of thrill, swelling, redness, pain, bleeding, or a cold/numb hand needs prompt dialysis-unit or medical review.
In this setting, the mildly prolonged aPTT is more likely related to dialysis heparin exposure than hemophilia, particularly if the sample was taken during or soon after dialysis.

Before

Reading File
If the blood sample was taken before dialysis, then the heparin given during that dialysis session would not explain the mildly prolonged aPTT.
Possible reasons then include:
  • Residual effect of heparin from an earlier dialysis session or heparin used to lock a dialysis catheter, if present
  • Other anticoagulant medicines
  • Liver dysfunction, vitamin K deficiency, or illness
  • A laboratory/sample issue
  • Less commonly, a clotting-factor deficiency or inhibitor
Because PT/INR and aPTT are mildly prolonged, the dialysis/nephrology doctor should review medications and consider repeating the test from a peripheral vein, before the next dialysis session. Avoid taking blood from the left AV fistula arm.

Uh, what is happening is, um, with that fistula, uh, we can't do dialysis. Because when we insert needle, uh... Because of blood loss, we can't do dialysis.

Reading File
Finding Sources
Finding Sources
Searching PubMed

hemodialysis arteriovenous fistula cannulation bleeding

Searching the Web

hemodialysis AV fistula needle site bleeding unable to dialyze emergency guidance

I understand. The problem is significant bleeding from the left AV fistula when dialysis needles are inserted, so dialysis cannot safely continue.
This needs urgent assessment today by the dialysis nephrologist and vascular-access surgeon/interventional radiology team. Do not keep trying repeated needle insertions into the fistula until the dialysis team assesses it.
Possible causes include:
  • A fistula problem such as narrowing (stenosis), an aneurysm/pseudoaneurysm, or damage at the needle site
  • Medicines that increase bleeding, including dialysis heparin, aspirin, clopidogrel, warfarin, or other anticoagulants
  • Reduced platelet function from kidney failure
  • The mildly prolonged PT/INR and aPTT shown in the report, which may contribute but do not alone establish the cause
  • Low platelets, anemia, liver/vitamin K problems, or an acquired clotting problem
The team may need to do:
  • CBC with platelet count and hemoglobin
  • Repeat PT/INR, aPTT, fibrinogen, and medication review
  • Fistula examination and Doppler ultrasound/fistulogram
  • Adjust or avoid heparin during dialysis if appropriate
  • Arrange temporary alternative access, such as a dialysis catheter, if dialysis is urgently required and the fistula cannot be used
If bleeding is happening now: apply firm, continuous direct pressure over the exact needle site with clean gauze. Do not repeatedly lift the gauze to check. If bleeding is heavy, soaks through, does not stop promptly with firm pressure, or the patient feels weak, dizzy, faint, short of breath, or confused, call emergency services or go to the emergency department immediately. Fistula bleeding can become dangerous quickly.
Also seek urgent assessment if the fistula has swelling, redness, pain, skin thinning, a lump, or if its usual buzzing/vibration disappears.

We have already done the doppler. The results were normal.

Reading File
Finding Sources
Finding Sources
Searching PubMed

hemodialysis arteriovenous fistula prolonged bleeding cannulation

Searching the Web

prolonged bleeding after hemodialysis fistula needle normal ultrasound causes heparin platelet dysfunction

A normal Doppler is reassuring. It means there is no obvious major blockage, clot, or major structural fistula problem seen on the scan.
But it does not rule out bleeding caused by the blood itself, or a needle/cannulation issue. In this situation, the more likely possibilities are:
  1. Dialysis-related bleeding tendency
    Kidney failure can make platelets work less effectively, called uremic platelet dysfunction. Platelet count may be normal, but the platelets may not seal the needle hole well.
  2. Medication effect
    Dialysis heparin, aspirin, clopidogrel, warfarin, or other blood thinners can make fistula puncture bleed excessively.
  3. Mild clotting-test abnormalities
    PT/INR 1.27 and aPTT 40 seconds are mildly prolonged. They may add to bleeding, but are usually not enough by themselves to explain major blood loss. They should be repeated from a peripheral vein and checked with a CBC, platelet count, hemoglobin, liver tests, fibrinogen, and medication review.
  4. Needle technique or puncture site issue
    Even with a normal Doppler, a needle can pass through the vessel wall, or a repeatedly used area can become fragile. The unit may use an experienced cannulator, ultrasound-guided cannulation, a different site, or a different needle size.
Ask the nephrologist specifically about:
  • Heparin-free dialysis or a reduced heparin dose
  • CBC, platelet count, hemoglobin, and repeat PT/INR/aPTT
  • Whether medicines such as aspirin or clopidogrel can be safely reviewed
  • Assessment for uremic platelet dysfunction and whether treatment is needed
  • Temporary dialysis access if dialysis is being missed because of bleeding
A normal Doppler does not mean the issue can be ignored. If dialysis cannot be performed, contact the nephrology/dialysis unit today, because missing dialysis can cause dangerous high potassium, fluid overload, and breathing problems.
This is a shared conversation. Sign in to Orris to start your own chat.